Prospective Study on Patients With Obstructive Sleep Apnea in Hong Kong (PrOSA)
1 other identifier
observational
1,000
1 country
1
Brief Summary
Obstructive sleep apnea syndrome (OSAS) is a common disorder with prevalence rates of at least 4% among the middle-aged male Caucasians and Hong Kong (HK) Chinese populations. It is characterized by repetitive episodes of upper airway obstruction, causing intermittent hypoxia, sleep fragmentation, disabling daytime sleepiness, impaired cognitive function and poor health status. OSAS patients are at increased risks of non-fatal and fatal cardiovascular morbidity and mortality including sudden death, in addition to being more prone to road traffic accidents. However, there is no long term follow up of patients with OSAS on the incidence of cardiovascular disease, compliance on the therapy and the impact of the quality of life. The study is aimed to carry out a prospective observational study assessing the role of OSAS as a possible cause of increased cardiovascular risk and cognitive decline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2020
CompletedFirst Submitted
Initial submission to the registry
August 31, 2020
CompletedFirst Posted
Study publicly available on registry
December 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 29, 2028
February 20, 2024
February 1, 2024
8 years
August 31, 2020
February 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of Cardiovascular disease
5 years
Secondary Outcomes (2)
Change of Montreal Cognitive Assessment score (MoCA)
5 years
Change of Epworth Sleepiness Score
5 years
Eligibility Criteria
Consecutive patients are recruited from the Respiratory Clinic at the Prince of Wales Hospital with clinical suspicion of sleep-disordered breathing. The Respiratory Clinic receives referral from hospital specialists and general practitioners. The clinical evaluation procedure includes an interview by a respiratory specialist followed by either an inpatient polysomnography or home polygraphic study according to the patients' clinical characteristics and preference in concordance of the guidelines from the American Academy of Sleep Medicine (AASM). Sleep records will be scored based on standardized criteria of AASM.
You may qualify if:
- suspected obstructive sleep apnea syndrome
- aged 18 or above
- must be able to speak, read and understand Chinese or English
- possess the ability to respond to questions and follow instructions.
You may not qualify if:
- already treated sleep apnea,
- a limited life expectancy due to illness unrelated to sleep apnea
- human immunodeficiency virus (HIV),
- advanced renal disease,
- uncontrolled malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese University of Hong
Hong Kong, Please Select, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 31, 2020
First Posted
December 9, 2020
Study Start
August 30, 2020
Primary Completion (Estimated)
August 29, 2028
Study Completion (Estimated)
August 29, 2028
Last Updated
February 20, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share